Intelligent Point‑of‑Care Biosensing Platform Based on Luminescent Nanoparticles and Microfluidic Biochip with Machine Vision Algorithm Analysis (IMAGE)
Caption
- A novel intelligent biosensing platform consisting of quantum dots luminescence and biochip with machine vision algorithm is proposed for point-of-care carcinoembryonic antigen (CEA) protein diagnostics.
- The designed diagnostic platform possesses outstanding detection limitation of approximately 0.021 ng mL-1 of CEA concentration compared with some commercial biodetection devices of lateral flow assay strips.
- The utilization of machine vision algorithm improves the detection features of portability and integration, which expands the potential of point-of-care biosensing applications.
Credit
Yuan Liu, Xinyue Lao, Man-Chung Wong, Menglin Song, Yifei Zhao, Yingjin Ma, Qianqian Bai, Jianhua Hao.
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.
License
CC BY-NC-ND